CIGNA (CI) Getting Positive Media Coverage, Accern Reports

News articles about CIGNA (NYSE:CI) have trended positive on Thursday, Accern Sentiment Analysis reports. The research firm rates the sentiment of press coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. CIGNA earned a news sentiment score of 0.33 on Accern’s scale. Accern also gave media coverage about the health services provider an impact score of 46.0410046156911 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

Here are some of the headlines that may have effected Accern Sentiment Analysis’s analysis:

A number of equities research analysts recently commented on CI shares. Piper Jaffray Companies reissued a “buy” rating and issued a $191.00 price objective on shares of CIGNA in a research note on Sunday, September 17th. Zacks Investment Research upgraded shares of CIGNA from a “hold” rating to a “buy” rating and set a $214.00 target price on the stock in a report on Monday, October 9th. Jefferies Group upped their target price on shares of CIGNA from $201.00 to $221.00 and gave the company a “buy” rating in a report on Friday, October 13th. BMO Capital Markets began coverage on shares of CIGNA in a report on Monday, October 16th. They set a “market perform” rating and a $210.00 price objective on the stock. Finally, Credit Suisse Group began coverage on shares of CIGNA in a report on Thursday, November 2nd. They set an “outperform” rating and a $219.00 price objective on the stock. Three analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has given a strong buy rating to the company. CIGNA presently has an average rating of “Buy” and an average target price of $205.18.

CIGNA (NYSE:CI) opened at $207.09 on Thursday. The stock has a market capitalization of $51,060.00, a PE ratio of 22.68, a P/E/G ratio of 1.44 and a beta of 0.51. CIGNA has a fifty-two week low of $133.52 and a fifty-two week high of $212.46. The company has a current ratio of 0.39, a quick ratio of 0.39 and a debt-to-equity ratio of 0.37.

CIGNA (NYSE:CI) last released its earnings results on Thursday, November 2nd. The health services provider reported $2.83 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.36 by $0.47. The firm had revenue of $10.38 billion for the quarter, compared to analyst estimates of $10.17 billion. CIGNA had a return on equity of 18.85% and a net margin of 5.74%. CIGNA’s revenue was up 5.1% compared to the same quarter last year. During the same period in the previous year, the company earned $1.94 earnings per share. analysts anticipate that CIGNA will post 10.34 EPS for the current year.

In related news, CAO Mary T. Hoeltzel sold 575 shares of the business’s stock in a transaction that occurred on Thursday, November 9th. The stock was sold at an average price of $197.03, for a total value of $113,292.25. Following the completion of the sale, the chief accounting officer now directly owns 2,499 shares in the company, valued at approximately $492,377.97. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Chairman Isaiah Harris, Jr. sold 212 shares of the business’s stock in a transaction that occurred on Monday, December 11th. The stock was sold at an average price of $209.35, for a total value of $44,382.20. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 34,936 shares of company stock worth $6,979,204. Company insiders own 1.30% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “CIGNA (CI) Getting Positive Media Coverage, Accern Reports” was originally reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this piece of content on another website, it was illegally copied and republished in violation of United States & international copyright and trademark legislation. The original version of this piece of content can be read at https://www.dispatchtribunal.com/2018/01/11/cigna-ci-getting-favorable-media-coverage-analysis-shows.html.

About CIGNA

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Insider Buying and Selling by Quarter for CIGNA (NYSE:CI)

Receive News & Ratings for CIGNA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CIGNA and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply